SCHEMBL14714715

SCHEMBL14714715

COc1ccc(C(N)(C(=O)OCc2cccc3c2Cc2ccccc2-3)c2ccc(O)cc2)c(OC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ PKM P14618 2/20 0.36
▸ PNMT P11086 1/20 0.36
▸ MAPT P10636 5/20 0.35
▸ KDM4E B2RXH2 5/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TAS1R3 Q7RTX0 1/20 0.32
▸ TAS1R1 Q7RTX1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31075128 0.85 ALDH1A1 (0.32) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL30381152 0.84 RAB9A (0.40) RAB9ANPC1PKMMAPTKDM4E
SCHEMBL29714449 0.84 NPC1 (0.35) RAB9ANPC1MAPTKDM4EALDH1A1
SCHEMBL38665543 0.84 RAB9A (0.40) RAB9ANPC1PKMMAPTKDM4E
SCHEMBL29387123 0.84 MAPT (0.34) RAB9ANPC1MAPTKDM4EALDH1A1
SCHEMBL28831144 0.82 NPC1 (0.35) RAB9ANPC1MAPTKDM4EALDH1A1
SCHEMBL26123782 0.82 RAB9A (0.40) RAB9ANPC1PKMMAPTKDM4E
SCHEMBL3485726 0.79 FABP5 (0.41) RAB9ANPC1KDM4EALDH1A1MEN1
SCHEMBL8229967 0.78 RAB9A (0.35) RAB9ANPC1PKMPNMTMAPT
SCHEMBL28918336 0.77 PNMT (0.43) RAB9ANPC1PNMTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2748183-B1 POTENT LIGANDS OF THE GHRELIN RECEPTOR UNIV LEIPZIG (DE) 2018-12-26 — — EP disclosed
US-9718861-B2 Potent ligands of the ghrelin receptor UNIVERSITAET LEIPZIG (DE) 2017-08-01 — — US disclosed
US-20150274781-A1 POTENT LIGANDS OF THE GHRELIN RECEPTOR UNIVERSITAET LEIPZIG (DE) 2015-10-01 — — US disclosed
EP-2748183-A1 POTENT LIGANDS OF THE GHRELIN RECEPTOR Universität Leipzig (DE) 2014-07-02 — — EP disclosed
WO-2013026927-A1 POTENT LIGANDS OF THE GHRELIN RECEPTOR UNIVERSITÄT LEIPZIG (DE) 2013-02-28 — — WO disclosed
EP-2562181-A1 Potent ligands of the ghrelin receptor Universität Leipzig (DE) 2013-02-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274781-A1 POTENT LIGANDS OF THE GHRELIN RECEPTOR GIPR, GPR119, GRPR RAB9A 1277/4885NPC1 1650/4885PKM 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback